Skip to main content

A new trial design for immunotherapy strategies and biomarkers of response

Intervista a Robert L. Ferris By 30 Novembre 2023No Comments
Congressi

Do we need a new trial design to develop novel immunotherapy strategies and biomarkers of response? And how Head and Neck cancer could be a model to follow? We asked Robert L. Ferris (Director UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine), that we met at Immunotherapy Bridge congress 2023 in Naples.